Key result
B-type natriuretic peptide testing showed high diagnostic accuracy for congestive heart failure, with an overall sensitivity of 81%, specificity of 86%, and an area under the S-ROC curve of 0.92.
Why the study?
Does B-type natriuretic peptide (BNP) testing accurately diagnose congestive heart failure in various clinical settings?
Meta-Analysis (n=11,054)
Does B-type natriuretic peptide (BNP) testing accurately diagnose congestive heart failure in various clinical settings?
Effect estimate: Sensitivity 81% (95% CI 0.76-0.86)
BNP testing demonstrates high diagnostic accuracy for congestive heart failure, particularly in patients presenting to the emergency department with dyspnea.
No takes yet. Share an insight, caveat, or question.
Supports BNP testing for acute HF diagnosis in dyspneic patients; reinforces pooled diagnostic accuracy across settings.
Elkhateeb et al. (2010) conducted a meta-analysis in Congestive heart failure (n=11,054). B-type natriuretic peptide (BNP) testing was evaluated on Diagnosis of congestive heart failure (sensitivity and specificity) (Sensitivity 81%, 95% CI 0.76-0.86). B-type natriuretic peptide testing showed high diagnostic accuracy for congestive heart failure, with an overall sensitivity of 81%, specificity of 86%, and an area under the S-ROC curve of 0.92.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: